{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:37:35Z","timestamp":1790617055065,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00945-9","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:47:25Z","timestamp":1748360845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ranolazine as a therapeutic agent for diabetic cardiomyopathy: reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model"],"prefix":"10.1186","volume":"26","author":[{"given":"Matin","family":"Mohyadini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aghele","family":"Fahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Zahra","family":"Bathaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7517-6807","authenticated-orcid":false,"given":"Hamid","family":"Yaghooti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"1","key":"945_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biology9010006","volume":"9","author":"LM Shawky","year":"2019","unstructured":"Shawky LM, Morsi AA, El Bana E, Hanafy SM. The biological impacts of sitagliptin on the pancreas of a rat model of type 2 diabetes mellitus: drug interactions with metformin. Biology. 2019;9(1):6.","journal-title":"Biology"},{"issue":"7","key":"945_CR2","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1007\/s00394-022-02898-9","volume":"61","author":"M Amiri","year":"2022","unstructured":"Amiri M, Raeisi-Dehkordi H, Moghtaderi F, Zimorovat A, Mohyadini M, Salehi-Abargouei A. The effects of sesame, canola, and sesame\u2013canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial. Eur J Nutr. 2022;61(7):3499\u2013516.","journal-title":"Eur J Nutr"},{"issue":"2","key":"945_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.17925\/HI.2024.18.2.2","volume":"18","author":"AJ Binu","year":"2024","unstructured":"Binu AJ, Kapoor N. Understanding Diabetic Cardiomyopathy: insulin Resistance and Beyond. Heart Int. 2024;18(2):7.","journal-title":"Heart Int"},{"key":"945_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.freeradbiomed.2015.08.009","volume":"89","author":"H Wu","year":"2015","unstructured":"Wu H, Kong L, Cheng Y, Zhang Z, Wang Y, Luo M, et al. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2. Free Radic Biol Med. 2015;89:431\u201342.","journal-title":"Free Radic Biol Med"},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"118306","DOI":"10.1016\/j.lfs.2020.118306","volume":"261","author":"X Chen","year":"2020","unstructured":"Chen X, Ren L, Liu X, Sun X, Dong C, Jiang Y, et al. Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1\/NRG1 pathway. Life Sci. 2020;261:118306.","journal-title":"Life Sci"},{"issue":"9","key":"945_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585\u2013607.","journal-title":"Nat Rev Cardiol"},{"key":"945_CR7","doi-asserted-by":"publisher","unstructured":"Bellemare M, Bourcier L, Iglesies-Grau J, Boulet J, O\u2019Meara E, Bouabdallaoui N. Mechanisms of diabetic cardiomyopathy: focus on inflammation. Diabetes Obes Metab. 2025 Feb 10. https:\/\/doi.org\/10.1111\/dom.16242","DOI":"10.1111\/dom.16242"},{"issue":"4","key":"945_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/antiox11040784","volume":"11","author":"B De Geest","year":"2022","unstructured":"De Geest B, Mishra M. Role of oxidative stress in diabetic cardiomyopathy. Antioxidants. 2022;11(4):784.","journal-title":"Antioxidants"},{"key":"945_CR9","doi-asserted-by":"crossref","unstructured":"Ebrahimi SM, Bathaie SZ, Faridi N, Taghikhani M, Nakhjavani M, Faghihzadeh S. L-lysine protects C2C12 myotubes and 3T3-L1 adipocytes against high glucose damages and stresses. PLoS One. 2019;14(12).","DOI":"10.1371\/journal.pone.0225912"},{"key":"945_CR10","doi-asserted-by":"publisher","first-page":"156062","DOI":"10.1016\/j.metabol.2024.156062","volume":"162","author":"I Congur","year":"2025","unstructured":"Congur I, Mingrone G, Guan K. Targeting endoplasmic reticulum stress as a potential therapeutic strategy for diabetic cardiomyopathy. Metabolism. 2025Jan;162: 156062.https:\/\/doi.org\/10.1016\/j.metabol.2024.156062.","journal-title":"Metabolism"},{"issue":"10","key":"945_CR11","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1002\/ptr.7773","volume":"38","author":"M Sanjari-Pour","year":"2024","unstructured":"Sanjari-Pour M, Faridi N, Wang P, Bathaie SZ. Protective effect of saffron carotenoids against amyloid b eta-induced neurotoxicity in differentiated PC12 cells via the unfolded protein response and autophagy. Phytother Res. 2024 Oct;38(10):4923\u201339. doi:https:\/\/doi.org\/10.1002\/ptr.7773.","journal-title":"Phytother Res"},{"issue":"3","key":"945_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","volume":"40","author":"D Senft","year":"2015","unstructured":"Senft D, Ze\u2019ev AR. UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci. 2015;40(3):141\u201348.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"945_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12967-025-06269-w","volume":"23","author":"E Radmehr","year":"2025","unstructured":"Radmehr E, Yazdanpanah N, Rezaei N. Non-coding RNAs affecting NLRP3 inflammasome pathway in diabetic cardiomyopathy: a comprehensive review of potential therapeutic options. J Transl Med. 2025;23(1):249.","journal-title":"J Transl Med"},{"key":"945_CR14","doi-asserted-by":"crossref","unstructured":"Rayner-Hartley E, Sedlak T. Ranolazine: a contemporary review. J Am Heart Assoc. 2016;5(3).","DOI":"10.1161\/JAHA.116.003196"},{"key":"945_CR15","doi-asserted-by":"publisher","first-page":"1207580","DOI":"10.3389\/fcvm.2023.1207580","volume":"10","author":"D Oksen","year":"2023","unstructured":"Oksen D, Aslan M, Ozmen E, Yavuz YE. Ranolazine improved left ventricular diastolic functions and ventricular repolarization indexes in patients with coronary slow flow. Front Cardiovasc Med. 2023;10:1207580.","journal-title":"Front Cardiovasc Med"},{"key":"945_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.recesp.2015.02.027","volume":"69","author":"EM Calderon-Sanchez","year":"2016","unstructured":"Calderon-Sanchez EM, Dominguez-Rodriguez A, Lopez-Haldon J, Jimenez-Navarro MF, Gomez AM, Smani T, et al. Cardioprotective Effect of Ranolazine in the Process of Ischemia-reperfusion in Adult Rat Cardiomyocytes. Rev Esp Cardiol (Engl Ed) 2016;69:45\u201353.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"945_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fphys.2018.00038","volume":"9","author":"G Riccio","year":"2018","unstructured":"Riccio G, Antonucci S, Coppola C, D\u2019Avino C, Piscopo G, Fiore D, et al. Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production. Front Physiol. 2018;9:38.","journal-title":"Front Physiol"},{"key":"945_CR18","first-page":"2953","volume":"27","author":"Z Dogan","year":"2023","unstructured":"Dogan Z, Durmus S, Ergun D, Gelisgen R, Uzun H. Ranolazine exhibits anti-inflammatory and antioxidant activities in H9c2 cardiomyocytes. Eur Rev Med Pharmacol Sci. 2023;27:2953\u201363.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"945_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1139\/cjpp-2018-0571","volume":"97","author":"MK Tawfik","year":"2019","unstructured":"Tawfik MK, Ameen AM. Cardioprotective effect of ranolazine in nondiabetic and diabetic male rats subjected to isoprenaline-induced acute myocardial infarction involves modulation of AMPK and inhibition of apoptosis. Can J Physiol Pharmacol. 2019;97(7):661\u201374.","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"945_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1258\/ebm.2012.011372","volume":"237","author":"T Szkudelski","year":"2012","unstructured":"Szkudelski T. Streptozotocin\u2013nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med. 2012;237(5):481\u201390.","journal-title":"Exp Biol Med"},{"issue":"4","key":"945_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1556\/APhysiol.101.2014.4.2","volume":"101","author":"A Ghasemi","year":"2014","unstructured":"Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes. Acta Physiol Hung. 2014;101(4):408\u201320.","journal-title":"Acta Physiol Hung"},{"key":"945_CR22","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.toxrep.2022.11.005","volume":"9","author":"S Samarghandian","year":"2022","unstructured":"Samarghandian S, Rajabi S, Aschner M, Noferesti V, Farkhondeh T. Oxidative stress and apoptotic index modifications in the hippocampus of rat pups born to mothers exposed to buprenorphine during lactation. Toxicol Rep. 2022;9:2050\u201354.","journal-title":"Toxicol Rep"},{"key":"945_CR23","doi-asserted-by":"publisher","first-page":"100718","DOI":"10.1016\/j.curtheres.2023.100718","volume":"99","author":"S Batoee","year":"2023","unstructured":"Batoee S, Etminaniesfahani M, Mazdeh M, Soltanian A, Nouri F. Evaluation of Rosuvastatin Therapy on SIRT1 Gene Expression in Patients with Multiple Sclerosis: an Uncontrolled Clinical Trial. Curr Ther Res. 2023;99:100718.","journal-title":"Curr Ther Res"},{"issue":"4","key":"945_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods. 2001;25(4):402\u201308.","journal-title":"Methods"},{"issue":"2","key":"945_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/01478885.2022.2105481","volume":"46","author":"AA Morsi","year":"2023","unstructured":"Morsi AA, Faruk EM, Medhat E, Taha NM, Ebrahim UFA. Modulatory effects of concomitant quercetin\/sitagliptin administration on the ovarian histological and biochemical alterations provoked by doxorubicin in a streptozotocin-induced diabetic rat model. J Histotechnol. 2023;46(2):65\u201379.","journal-title":"J Histotechnol"},{"key":"945_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","volume":"169","author":"NJ Byrne","year":"2021","unstructured":"Byrne NJ, Rajasekaran NS, Abel ED, Bugger H. Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radic Biol Med. 2021;169:317\u201342.","journal-title":"Free Radic Biol Med"},{"key":"945_CR27","doi-asserted-by":"publisher","first-page":"7086512","DOI":"10.1155\/2021\/7086512","volume":"2021","author":"U Ganguly","year":"2021","unstructured":"Ganguly U, Kaur U, Chakrabarti SS, Sharma P, Agrawal BK, Saso L, et al. Oxidative stress, neuroinflammation, and NADPH oxidase: implications in the pathogenesis and treatment of Alzheimer\u2019s disease. Oxid Med Cell Longev 2021;2021:7086512.","journal-title":"Oxid Med Cell Longev"},{"key":"945_CR28","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1111\/bph.13791","volume":"174","author":"D Cappetta","year":"2017","unstructured":"Cappetta D, Esposito G, Coppini R, Piegari E, Russo R, Ciuffreda LP, et al. Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction. Br J Pharmacol 2017;174:3696\u2013712.","journal-title":"Br J Pharmacol"},{"key":"945_CR29","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.1002\/jcp.27791","volume":"234","author":"J Nie","year":"2019","unstructured":"Nie J, Duan Q, He M, Li X, Wang B, Zhou C, et al. Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling. J Cell Physiol 2019;234:11587\u2013601.","journal-title":"J Cell Physiol"},{"issue":"3","key":"945_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/ijms17030327","volume":"17","author":"HMA Zeeshan","year":"2016","unstructured":"Zeeshan HMA, Lee GH, Kim H-R, Chae H-J. Endoplasmic reticulum stress and associated ROS. Int J Mol Sci. 2016;17(3):327.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"945_CR31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.4103\/ijmr.IJMR_1504_16","volume":"148","author":"R Naveena","year":"2018","unstructured":"Naveena R, Hashilkar NK, Davangeri R, Majagi SI. Effect of anti-inflammatory activity of ranolazine in rat model of inflammation. Indian J Med Res. 2018;148(6):743\u201347.","journal-title":"Indian J Med Res"},{"key":"945_CR32","doi-asserted-by":"publisher","first-page":"20138","DOI":"10.1038\/s41598-023-47540-8","volume":"13","author":"I Piano","year":"2023","unstructured":"Piano I, Votta A, Colucci P, Corsi F, Vitolo S, Cerri C, et al. Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for Ranolazine. Sci Rep 2023;13:20138.","journal-title":"Sci Rep"},{"key":"945_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/nu12020382","volume":"12","author":"V Cassano","year":"2020","unstructured":"Cassano V, Leo A, Tallarico M, Nesci V, Cimellaro A, Fiorentino TV, et al. Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: data from an in vivo model. Nutrients 2020;12:382.","journal-title":"Nutrients"},{"issue":"2","key":"945_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4093\/dmj.2020.0285","volume":"45","author":"W-S Lee","year":"2021","unstructured":"Lee W-S, Kim J. Application of animal models in diabetic cardiomyopathy. Diabetes Metab J. 2021;45(2):129\u201345.","journal-title":"Diabetes Metab J"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00945-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:47:27Z","timestamp":1748360847000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00945-9","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures adhered to the ethical guidelines of animal studies and were approved by the Ethical Committee of Tarbiat Modares University (IR.MODARES.AEC.1401, 022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}